MGO One Seven
ECYT

MGO One Seven’s Endocyte, Inc. Common Stock ECYT Stock Holding History

MGO One Seven’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$9K Hold
1,000
– – ﹤0.01% 1147
2017
Q4 		$4K Buy
+1,000
New +$4.76K ﹤0.01% 1403

Other funds holding ECYT

Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

MGO One Seven's ECYT Position: Q1 2018 in Review

MGO One Seven held its Endocyte, Inc. Common Stock (ECYT) position steady in Q1 2018 at 1,000 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #1147.

MGO One Seven first reported a position in ECYT in Q4 2017 and has held it in 2 quarters since. 89 funds tracked by Wall St. Rank hold ECYT as of Q1 2018.

  • MGO One Seven held 1,000 shares of Endocyte, Inc. Common Stock worth $9K as of Q1 2018.
  • MGO One Seven left its Endocyte, Inc. Common Stock share count unchanged in Q1 2018.
  • Endocyte, Inc. Common Stock made up ﹤0.01% of MGO One Seven's portfolio in Q1 2018, its #1147 holding.
  • MGO One Seven first reported a position in Endocyte, Inc. Common Stock in Q4 2017 and has held it in 2 quarters since.
  • 89 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q1 2018.

Based on MGO One Seven's 13F filing for Q1 2018, filed 15 May 2018.